Search research articles
Contact Us
Filters
Showing results (1-10 of 61) with videos related to
Page
of 7
Sort By:
Best Practice & Research. Clinical Rheumatology
|
March 11, 2008
Sclerosing bone disorders
Marie-Christine de Vernejoul
Annals of the New York Academy of Sciences
|
April 16, 2010
Heritable sclerosing bone disorders: presentation and new molecular mechanisms
Marie-Christine de Vernejoul, Uwe Kornak
Joint Bone Spine
|
February 3, 2009
Impact of combined and progestogen-only contraceptives on bone mineral density
Julie Sarfati, Marie-Christine de Vernejoul
Therapie
|
December 20, 2003
[Bone remodeling]
Martine Cohen-Solal, Marie-Christine de Vernejoul
Biochemical and Biophysical Research Communications
|
September 11, 2004
RAMPs and CRLR expressions in osteoblastic cells after dexamethasone treatment
Benjamin Uzan, Marie-Christine de Vernejoul, Michèle Cressent
Critical Reviews in Eukaryotic Gene Expression
|
August 30, 2007
Role of DLX regulatory proteins in osteogenesis and chondrogenesis
Nadeem Samee, Marie-Christine de Vernejoul, Giovanni Levi
Joint Bone Spine
|
April 27, 2005
LRP5 mutations in osteoporosis-pseudoglioma syndrome and high-bone-mass disorders
Régis Levasseur, Didier Lacombe, Marie Christine de Vernejoul
Bonekey Reports
|
August 17, 2013
Serotonin: good or bad for bone
Marie-Christine de Vernejoul, Corinne Collet, Yasmine Chabbi-Achengli
Journal of Cellular Biochemistry
|
April 4, 2008
Inhibition of osteoblastic metalloproteinases in mice prevents bone loss induced by oestrogen deficiency
Corinne Schiltz, Caroline Marty, Marie-Christine de Vernejoul, et al.
The Journal of Steroid Biochemistry and Molecular Biology
|
October 22, 2003
Dexamethasone decreases phospholipase C beta1 isozyme expression in human vascular smooth muscle cells
Carine Cueille, Stéphane Frayon, Marie-Christine de Vernejoul, et al.
Page
of 7
Search research articles
Search
Showing results (1-10 of 61) with videos related to
Sort By:
Page
of 7
Best Practice & Research. Clinical Rheumatology
|
March 11, 2008
Sclerosing bone disorders
Marie-Christine de Vernejoul
Annals of the New York Academy of Sciences
|
April 16, 2010
Heritable sclerosing bone disorders: presentation and new molecular mechanisms
Marie-Christine de Vernejoul, Uwe Kornak
Joint Bone Spine
|
February 3, 2009
Impact of combined and progestogen-only contraceptives on bone mineral density
Julie Sarfati, Marie-Christine de Vernejoul
Therapie
|
December 20, 2003
[Bone remodeling]
Martine Cohen-Solal, Marie-Christine de Vernejoul
Biochemical and Biophysical Research Communications
|
September 11, 2004
RAMPs and CRLR expressions in osteoblastic cells after dexamethasone treatment
Benjamin Uzan, Marie-Christine de Vernejoul, Michèle Cressent
Critical Reviews in Eukaryotic Gene Expression
|
August 30, 2007
Role of DLX regulatory proteins in osteogenesis and chondrogenesis
Nadeem Samee, Marie-Christine de Vernejoul, Giovanni Levi
Joint Bone Spine
|
April 27, 2005
LRP5 mutations in osteoporosis-pseudoglioma syndrome and high-bone-mass disorders
Régis Levasseur, Didier Lacombe, Marie Christine de Vernejoul
Bonekey Reports
|
August 17, 2013
Serotonin: good or bad for bone
Marie-Christine de Vernejoul, Corinne Collet, Yasmine Chabbi-Achengli
Journal of Cellular Biochemistry
|
April 4, 2008
Inhibition of osteoblastic metalloproteinases in mice prevents bone loss induced by oestrogen deficiency
Corinne Schiltz, Caroline Marty, Marie-Christine de Vernejoul, et al.
The Journal of Steroid Biochemistry and Molecular Biology
|
October 22, 2003
Dexamethasone decreases phospholipase C beta1 isozyme expression in human vascular smooth muscle cells
Carine Cueille, Stéphane Frayon, Marie-Christine de Vernejoul, et al.
Page
of 7